Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for ADPT.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 159.06M
March 31, 2026 159.70M
December 31, 2025 153.78M
September 30, 2025 152.58M
June 30, 2025 152.23M
March 31, 2025 151.92M
December 31, 2024 147.77M
September 30, 2024 147.56M
June 30, 2024 147.46M
March 31, 2024 147.37M
December 31, 2023 145.08M
September 30, 2023 144.77M
June 30, 2023 144.65M
March 31, 2023 144.28M
December 31, 2022 143.10M
September 30, 2022 142.99M
Date Value
June 30, 2022 142.78M
March 31, 2022 142.18M
December 31, 2021 141.39M
September 30, 2021 141.03M
June 30, 2021 140.66M
March 31, 2021 139.88M
December 31, 2020 137.65M
September 30, 2020 136.39M
June 30, 2020 128.23M
March 31, 2020 126.62M
December 31, 2019 125.24M
September 30, 2019 124.32M
June 30, 2019 124.29M
March 31, 2019 123.22M
June 30, 2018 124.29M
March 31, 2018 123.22M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
Personalis, Inc. 106.37M
10X Genomics, Inc. 130.28M
Alamar Biosciences, Inc. (California) 69.39M
Champions Oncology, Inc. 13.89M
Medpace Holdings, Inc. 27.84M